Ischemic Optic Neuropathy
Definition
Infarction of the optic nerve head due to vascular insufficiency, classified as non-arteritic (NAION) or arteritic (AAION, associated with giant cell arteritis), presenting with acute, painless visual loss and characteristic disc edema.
Clinical Snapshot
Ischemic optic neuropathy (ION) results from infarction of the optic nerve head due to vascular insufficiency. The critical distinction is between non-arteritic (NAION) and arteritic (AAION) forms. AAION is caused by giant cell arteritis (GCA) — a systemic granulomatous vasculitis — and is an ophthalmic emergency requiring immediate high-dose systemic corticosteroids to prevent fellow eye involvement. NAION is the more common form, associated with systemic vascular risk factors and a "disc at risk" (small cup-to-disc ratio).
Epidemiology
NAION is the most common acute optic neuropathy in adults over 50, with an annual incidence of approximately 2–10 per 100,000. AAION is less common but more devastating — GCA affects approximately 15–25 per 100,000 adults over 50, with ocular involvement in 15–20% of cases.
Pathophysiology
NAION results from ischemia of the short posterior ciliary arteries supplying the optic nerve head, in the context of a structurally crowded disc (small cup-to-disc ratio, "disc at risk") and systemic vascular risk factors. AAION results from granulomatous inflammation of the posterior ciliary arteries in GCA, causing complete occlusion and infarction of the optic nerve head.
Risk Factors
- NAION: small cup-to-disc ratio ("disc at risk"), hypertension, diabetes, hyperlipidemia, sleep apnea, phosphodiesterase-5 inhibitor use
- AAION: age > 50, female sex, GCA symptoms (headache, jaw claudication, scalp tenderness, polymyalgia rheumatica)
Clinical Presentation
Both forms: acute, painless, monocular visual loss with altitudinal visual field defect and disc edema. NAION: segmental disc edema, often with peripapillary hemorrhages; small cup-to-disc ratio in the fellow eye. AAION: diffuse chalky-white disc edema; systemic GCA symptoms; markedly elevated ESR and CRP.
Diagnostic Pearls
- Any acute painless visual loss with disc edema in an adult over 50 requires immediate evaluation for GCA — ESR, CRP, and CBC are urgent.
- Jaw claudication is the most specific symptom of GCA — ask about it in every patient with suspected AAION.
- The fellow eye in NAION has a small cup-to-disc ratio ("disc at risk") — document this finding.
- Temporal artery biopsy is the gold standard for GCA diagnosis — do not delay corticosteroids pending biopsy.
Differential Diagnosis
- Optic neuritis (pain with eye movement, younger patients)
- Central retinal artery occlusion
- Compressive optic neuropathy
- Diabetic papillopathy
Evidence-Based Management
AAION: immediate high-dose systemic corticosteroids (IV methylprednisolone 1g/day for 3 days, then oral prednisone 1 mg/kg/day) — do not wait for biopsy results. Temporal artery biopsy within 1–2 weeks. NAION: no proven treatment; systemic vascular risk factor management (blood pressure, diabetes, hyperlipidemia, sleep apnea); avoid nocturnal hypotension; aspirin is commonly used but not proven.
Monitoring & Follow-Up
AAION: monitor ESR/CRP and taper corticosteroids guided by inflammatory markers and symptoms. NAION: monitor fellow eye — risk of fellow eye involvement is approximately 15–25% over 5 years.
Clinical Pearls
- AAION is an emergency — immediate corticosteroids before biopsy is the standard of care; biopsy remains positive for 1–2 weeks after starting steroids.
- The fellow eye in NAION is at risk — document the "disc at risk" and counsel the patient.
- Sleep apnea is an underappreciated risk factor for NAION — screen and treat.
- Phosphodiesterase-5 inhibitors (sildenafil, tadalafil) have been associated with NAION — counsel patients with a "disc at risk."
Related Therapeutics — Clinician's Companion
- Oral Therapeutics — Oral Prednisone (Clinician's Companion)
Key References
- 1.Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009.
- 2.Biousse V, Newman NJ. Ischemic optic neuropathies. N Engl J Med. 2015.
This entry is an educational reference designed to support clinical reasoning and awareness. It does not constitute medical advice, establish a standard of care, or replace individualized patient assessment. Clinicians should consult current guidelines and applicable clinical resources when making patient care decisions.